DI STEFANO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 9.142
EU - Europa 6.621
AS - Asia 6.198
SA - Sud America 666
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 4
Totale 22.728
Nazione #
US - Stati Uniti d'America 8.970
SG - Singapore 2.589
CN - Cina 1.688
IT - Italia 1.417
IE - Irlanda 861
UA - Ucraina 792
GB - Regno Unito 690
RU - Federazione Russa 636
SE - Svezia 624
VN - Vietnam 619
TR - Turchia 552
FR - Francia 551
BR - Brasile 535
DE - Germania 487
IN - India 312
FI - Finlandia 208
HK - Hong Kong 112
CA - Canada 91
BD - Bangladesh 65
PL - Polonia 65
MX - Messico 55
BE - Belgio 50
ES - Italia 50
AR - Argentina 49
JP - Giappone 44
AT - Austria 38
CZ - Repubblica Ceca 35
IQ - Iraq 34
NL - Olanda 27
KR - Corea 26
ZA - Sudafrica 25
IR - Iran 22
LT - Lituania 21
ID - Indonesia 18
CO - Colombia 17
PK - Pakistan 17
EC - Ecuador 16
SA - Arabia Saudita 16
KE - Kenya 13
MA - Marocco 13
GR - Grecia 12
UZ - Uzbekistan 12
VE - Venezuela 12
JO - Giordania 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
EU - Europa 10
PE - Perù 10
TN - Tunisia 10
EG - Egitto 9
IL - Israele 9
CH - Svizzera 8
PY - Paraguay 8
AZ - Azerbaigian 7
RO - Romania 7
AL - Albania 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EE - Estonia 5
JM - Giamaica 5
NP - Nepal 5
CR - Costa Rica 4
KZ - Kazakistan 4
MY - Malesia 4
PA - Panama 4
PH - Filippine 4
PT - Portogallo 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
CG - Congo 3
ET - Etiopia 3
HU - Ungheria 3
LB - Libano 3
NO - Norvegia 3
TH - Thailandia 3
BB - Barbados 2
CI - Costa d'Avorio 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
MD - Moldavia 2
RS - Serbia 2
SR - Suriname 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 22.717
Città #
Singapore 1.967
Chandler 1.123
Jacksonville 929
San Jose 917
Dublin 848
Ashburn 650
Southend 460
Dallas 438
Beijing 389
Princeton 373
Chieti 331
Izmir 300
Nanjing 266
Santa Clara 230
Dearborn 228
Los Angeles 216
The Dalles 206
Ho Chi Minh City 203
Ann Arbor 200
Wilmington 175
New York 174
Munich 150
Cambridge 146
Hanoi 144
Altamura 143
Tongling 118
Pescara 110
Hong Kong 96
Nanchang 95
Boardman 90
Buffalo 90
Moscow 79
Shenyang 67
São Paulo 59
Council Bluffs 55
Tianjin 54
Woodbridge 53
Brussels 48
Hebei 48
Kunming 48
Redondo Beach 48
Frankfurt am Main 45
Hefei 44
Washington 43
Tokyo 42
Warsaw 42
Orem 40
Helsinki 39
Rome 39
Houston 36
Chennai 32
Da Nang 32
Montreal 32
Brno 31
Jinan 30
Milan 30
Grevenbroich 29
Kocaeli 29
Zhengzhou 29
Denver 28
Dong Ket 28
London 28
Atlanta 27
Brooklyn 26
Falls Church 26
Jiaxing 26
Turku 26
Chicago 25
Haiphong 25
Leawood 25
Nuremberg 25
Seattle 25
Toronto 24
Mexico City 23
Vienna 23
Augusta 22
Boston 22
Poplar 22
Seoul 22
Hangzhou 20
Johannesburg 20
San Mateo 20
Ningbo 19
Norwalk 19
Stockholm 19
Guangzhou 18
San Francisco 18
Manchester 17
Ancona 16
Changsha 16
Bologna 15
Lanciano 15
Rio de Janeiro 15
Ardabil 14
Auburn Hills 14
Biên Hòa 14
Brasília 14
Lanzhou 14
Paris 14
Silvi 14
Totale 13.851
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 237
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 201
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 199
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 191
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 184
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 183
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 178
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 171
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 169
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 164
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 163
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 163
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 159
Au nanoparticles functionalized by newly synthetised antiparkinson prodrugs 158
NSAID Coniugates for the treatment of Alzheimer's Disease 158
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 156
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 156
Carvacrol prodrugs as novel antimicrobial agents 156
Carvacrol codrugs: A new approach in the antimicrobial plan 155
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 154
Zingiberene attenuates hydrogen peroxide-induced toxicity in neuronal cells 154
Synthesis of a novel TRH-related sulphonamido peptide 153
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 153
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 153
Advances in prodrug design for Parkinson's disease 153
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 152
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 151
Effect of MRJF4 on C6 glioma cells proliferation and migration 151
Health risk assessments of lithium titanate nanoparticles in rat liver cell model for its safe applications in nanopharmacology and nanomedicine 149
A novel TRH analog containing a gamma-sultam residue replacing the pyroglutamic acid 148
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 146
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 146
Carvacrol and its derivatives as antibacterial agents 146
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 145
Antiparkinson Prodrugs 144
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 143
Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4], L121, and Triton X-100 142
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 142
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 141
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 141
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 140
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 139
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 139
Synthesis and antioxidant properties of novel memantine derivatives 139
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 138
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 136
Activity of N-(2-phenylethyl)-N-n-propyl-(2-(3-hydroxyphenyl)ethylamine derivates as dopamine receptor ligands 136
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 136
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 136
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 136
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 136
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 135
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 135
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 134
Synthesis and preliminary pharmacological evaluation of 5-hydroxy and 5,6-dihydroxy-benzo(5,6)cyclohept(1,2,3-ij)isoquinoline derivatives as dopamine receptor ligands 133
“Evaluation of endocrine disruptors, TPHPand DPHP, effect on DNA repair damage pathwais in a normal human thyroid cell model” 133
Graphene Oxide increases mammalian spermatozoa fertilizing ability by extracting cholesterol from their membranes and promoting capacitation 132
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 131
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 131
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 130
New drug delivery strategies for improved Parkinson’s disease therapy 129
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 129
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 129
HPLC–FLD and spectrofluorometer apparatus: How to best detect fluorescent probe-loaded niosomes in biological samples 129
Analytical Methods to Best Detect Fluorescent Probe Loading Nanoparticles in Biological Samples 129
Stimulation of Human Macrophages (THP-1) using Toll-like Receptor-2 (TLR-2) Agonist Decorated Nanocarriers 128
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 128
Inside Cover: Single-Walled Carbon Nanotubes in Highly Viscous Media: A Comparison between the Dispersive Agents [BMIM][BF4 ], L121, and Triton X-100 (Chem. Eur. J. 2/2016) 128
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 127
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 127
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands. 126
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 126
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 126
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 125
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 125
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 125
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 124
Designing Prodrugs for the Treatment of Parkinson's Disease 124
Synthesis of a novel glutathione analogue as potential inhibitor of glutathione-S-transferase 123
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 123
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 123
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 122
Toll-like receptor-2 agonist functionalized biopolymer for mucosal vaccination 122
Multiple lipid nanoparticles as antimicrobial drug delivery systems 122
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 121
Evidence for a Dopamine Intrinsic Direct Role in the Regulation of the Ovary Reproductive Function: In Vitro Study on Rabbit Corpora Lutea 121
In vitro evaluation of the potential anticancer activity of new memantin co-drugs on rat C6 glioblastoma cells 121
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 121
L-Dopa- and dopamine- (R)-α-lipoic acid conjugates as multifunctional codrugs with antioxidant properties 119
Drug Delivery Strategies for Alzheimer's Disease Treatment 119
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 118
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 118
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 118
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 118
Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model 118
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 117
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 117
Transdermal donepezil on the treatment of Alzheimer’s disease 117
NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer’s Disease, in response to a new lipophilic molecular combination codrug-1 116
Cytotoxicity and genotoxicity of iron oxide nanoparticles: An in vitro biosafety study 116
Totale 14.027
Categoria #
all - tutte 91.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021361 0 0 0 0 0 0 0 0 0 151 136 74
2021/2022918 33 32 13 94 93 33 34 61 131 42 89 263
2022/20233.067 235 464 178 332 280 584 153 281 367 47 66 80
2023/20241.486 99 82 102 54 94 461 318 55 20 24 27 150
2024/20253.806 192 720 616 122 50 225 100 199 312 170 472 628
2025/20267.022 684 363 737 909 693 462 1.382 489 773 530 0 0
Totale 23.347